EUVIMEDEUVIMED entdecken
Crossref

Synthesis, DFT and molecular docking studies of N-Heterocyclic carbene selenium compounds conferring anticancer and antibacterial activity

Ahmad Hassan, Rizwan Ashraf, Muhammad Adnan Iqbal, Khizar Hayat, Faisal Jamil, Saed Ayidh Althobaiti, Syeda Anjum Tahira, Mohamed El-Naggar, Mohamed Mohamed Soliman

Archives of Biochemistry and Biophysics · 2025-11 · 773 · 110598

DOI: 10.1016/j.abb.2025.110598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025-11. Verfasst von Ahmad Hassan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Agriculture, Faisalabad, Pakistan; Organometallic and Coordination Chemistry Laboratory, University of Agricul…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Antineoplastic Agents, Anti-Bacterial Agents, Methane. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Taif University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Target based drug design is an important strategy that increases the selectivity, efficacy and safety of drug candidates. In this study we designed synthesis of benz-imidazolium salts (L1-L3) and selenium compounds (C1-C3) to investigate their enzyme inhibition potential and bioactivity. Successful synthesis was confirmed through analytical techniques like UV-Vis., FTIR, 1H & 13C NMR and mass spectrometry that further supported by computational (DFT) studies. Molecular docking studies of C1-C3 against key molecular targets (COX-1, EGF, VEGF and HIF) was conducted. Among the test compounds C1 showed an impressive binding affinity of -6.14 kcal mol-1 against EGF which is comparable to standard drug 5-FU (-4.97 kcal mol-1). The validation of docking results through in vitro studies confirmed C1 as most potent inhibitor among the test compounds, having inhibition of 67.4 ± 1.3 % and 86.7 ± 1.8 % against COX-1 and EGF respectively. Furthermore, test compounds showed significant inhibition potential against thioredoxin reductase (TrxR). Cytotoxicity profiling across HepG2, HeLa and A-2780 cell lines confirmed C1 as the lead compound, with IC50 values of 0.956, 1.986, and 0.862 μg/mL, respectively. Test compounds also showed antibacterial activity by showing inhibition zone 8.5 ± 1.1-27.0 ± 1.2 mm against E. coli and S. aureus. These findings showed that NHC based selenium compounds could be a potential drug candidate for chemotherapy against multiple cancerous strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationAntineoplastic AgentsAnti-Bacterial AgentsMethaneSelenium CompoundsHeterocyclic CompoundsHumansDensity Functional TheoryCell Line, TumorThioredoxin-Disulfide ReductaseEscherichia coli

Stichwörter der Autor:innen

CytotoxicityDFT studiesEnzyme inhibitionN-Heterocyclic carbenes

Substanzen

Antineoplastic AgentsAnti-Bacterial AgentsMethanecarbeneSelenium CompoundsHeterocyclic CompoundsThioredoxin-Disulfide Reductase

Autor:innen und Institutionen

  • Department of Chemistry, University of Agriculture, Faisalabad, Pakistan; Organometallic and Coordination Chemistry Laboratory, University of Agriculture, Faisalabad, 38040, Pakistan.
  • Department of Chemistry, University of Agriculture, Faisalabad, Pakistan. Electronic address: rizi_chem82@hotmail.com.
  • Department of Chemistry, University of Agriculture, Faisalabad, Pakistan; Organometallic and Coordination Chemistry Laboratory, University of Agriculture, Faisalabad, 38040, Pakistan. Electronic address: adnan.iqbal@uaf…
  • Department of Chemistry Quaid-i-Azam University, Islamabad, 45320, Pakistan.
  • Department of Chemistry, University of Agriculture, Faisalabad, Pakistan.
  • Biology Department, Turabah University College, Taif University, Taif, 21944, Saudi Arabia.

Förderung

  • Taif University

Zitieren

APA

Hassan, A., Ashraf, R., Iqbal, M. A., Hayat, K., Jamil, F., Althobaiti, S. A., Tahira, S. A., El-Naggar, M., & Soliman, M. M. (2025). Synthesis, DFT and molecular docking studies of N-Heterocyclic carbene selenium compounds conferring anticancer and antibacterial activity. Archives of Biochemistry and Biophysics, 773, 110598. https://doi.org/10.1016/j.abb.2025.110598

Vancouver

Hassan A, Ashraf R, Iqbal MA, Hayat K, Jamil F, Althobaiti SA, et al. Synthesis, DFT and molecular docking studies of N-Heterocyclic carbene selenium compounds conferring anticancer and antibacterial activity. Archives of Biochemistry and Biophysics. 2025;773:110598. doi:10.1016/j.abb.2025.110598

BibTeX
@article{Hassan2025,
  author = {Hassan, Ahmad and Ashraf, Rizwan and Iqbal, Muhammad Adnan and Hayat, Khizar and Jamil, Faisal and Althobaiti, Saed Ayidh and Tahira, Syeda Anjum and El-Naggar, Mohamed and Soliman, Mohamed Mohamed},
  title = {Synthesis, DFT and molecular docking studies of N-Heterocyclic carbene selenium compounds conferring anticancer and antibacterial activity},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  volume = {773},
  pages = {110598},
  doi = {10.1016/j.abb.2025.110598}
}
Kostenlos starten →